Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;14(3):741-749.
doi: 10.1007/s13311-017-0531-1.

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective

Ben Sessa  1
Affiliations
Review

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective

Ben Sessa. Neurotherapeutics. 2017 Jul.

Abstract

Since the late 1980s the psychoactive drug 3,4-methylenedioxymethamphetamine (MDMA) has had a well-known history as the recreationally used drug ecstasy. What is less well known by the public is that MDMA started its life as a therapeutic agent and that in recent years an increasing amount of clinical research has been undertaken to revisit the drug's medical potential. MDMA has unique pharmacological properties that translate well to its proposed agent to assist trauma-focused psychotherapy. Psychological trauma-especially that which arises early in life from child abuse-underpins many chronic adult mental disorders, including addictions. Several studies of recent years have investigated the potential role of MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder, with ongoing plans to see MDMA therapy licensed and approved within the next 5 years. Issues of safety and controversy frequently surround this research, owing to MDMA's often negative media-driven bias. However, accurate examination of the relative risks and benefits of clinical MDMA-in contrast to the recreational use of ecstasy-must be considered when assessing its potential benefits and the merits of future research. In this review, the author describes these potential benefits and explores the relatives risks of MDMA-assisted psychotherapy in the context of his experience as a child and adolescent psychiatrist, having seen the relative limitations of current pharmacotherapies and psychotherapies for treating complex post-traumatic stress disorder arising from child abuse.

Keywords: MDMA; PTSD; Psychedelics; Psychotherapy; Trauma; addictions.

PubMed Disclaimer

References

    1. Lee A, Hankin BL. Insecure attachment, dysfunctional attitudes, and low self-esteem predicting prospective symptoms of depression and anxiety during adolescence. J Clin Child Adolesc Psychol. 2009;38(2):219–231. doi: 10.1080/15374410802698396. - DOI - PMC - PubMed
    1. Streeck-Fischer A, van der Kolk B. Down will come baby, cradle and all: diagnostic and therapeutic implications of chronic trauma on child development. Aust N Z J Psychiatry 2000. 2000;34(6):903–918. doi: 10.1080/000486700265. - DOI - PubMed
    1. Rauch SL, Whalen PJ, Shin LM. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry. 2000;47(9):769–776. doi: 10.1016/S0006-3223(00)00828-3. - DOI - PubMed
    1. Brady KT, Back SE, Coffey SF. Substance abuse and posttraumatic stress disorder. Curr Dir Psychol Sci. 2004;13:206–209. doi: 10.1111/j.0963-7214.2004.00309.x. - DOI
    1. Ferry F, Bolton D, Bunting B, Devine B, McCann S, Murphy S. (2008) Trauma, health and conflict in Northern Ireland: a study of the epidemiology of trauma related disorder and qualitative investigation of the impact of trauma on the individual. The Northern Ireland Centre for Trauma and Transformation and the Psychology Research Institute, University of Ulster. Available at: http://icrt.org.uk/wp-content/uploads/2012/11/08-May-Trauma-Health-Confl.... Accessed 13 April 2017.

MeSH terms

Substances